CN Patent
CN112094269B — 一类饱和六元环并杂环类化合物、制备方法和用途
Assigned to Shanghai Lingji Biotechnology Co Ltd · Expires 2021-12-07 · 4y expired
What this patent protects
本发明公开了一类饱和六元环并杂环类化合物、制备方法和用途。一种如通式I所示的饱和六元环并杂环类化合物、或其药学上可接受的盐、或其对映异构体、非对映异构体、互变异构体、扭转异构体、溶剂化物、多晶型物或前药、其制备方法及在药学上的应用,其中各基团的定义如说明书中所述。
USPTO Abstract
本发明公开了一类饱和六元环并杂环类化合物、制备方法和用途。一种如通式I所示的饱和六元环并杂环类化合物、或其药学上可接受的盐、或其对映异构体、非对映异构体、互变异构体、扭转异构体、溶剂化物、多晶型物或前药、其制备方法及在药学上的应用,其中各基团的定义如说明书中所述。
Drugs covered by this patent
- Krazati (ADAGRASIB) · Bristol-Myers Squibb
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.